Recall Record

Jadcherla Mandal, Mahaboob Nagar, India

Hetero Labs Limited Unit V recalls

7 recalls recorded since 2018, most recently on 26 March 2026. 2 are listed as ongoing. Status and classification are as published by the FDA.

Recalls7
Ongoing (FDA)2
Terminated or completed5
Class I (FDA)1

Ongoing Class II Drugs

Recall started
26 March 2026
Reason
Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Distribution
Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall number
D-0484-2026

Terminated Class II Drugs

Recall started
6 August 2020
Terminated
24 January 2022
Reason
Failed Tablet/Capsule Specification; complaint of bulging tablet
Distribution
Product was distributed to major wholesalers/distributors throughout the United States.
Initiated
Voluntary: Firm initiated
Recall number
D-1545-2020

Terminated Class II Drugs

Recall started
20 August 2018
Terminated
5 November 2021
Reason
Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-1213-2018

Ongoing Class I Drugs

Recall started
15 August 2018
Reason
Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg.
Distribution
U.S.A. Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0081-2019

Completed Class II Drugs

Recall started
8 August 2018
Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-1116-2018, D-1113-2018, D-1115-2018, D-1114-2018

Terminated Class II Drugs

Recall started
13 February 2018
Terminated
18 February 2021
Reason
Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).
Distribution
NJ and then distributed Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall numbers
D-0602-2018, D-0601-2018

Terminated Class II Drugs

Recall started
22 December 2017
Terminated
5 February 2020
Reason
Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged exposure to high temp during distribution.
Distribution
Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall number
D-0415-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.